Clinical Trials
3 trialsNCT04503694 2026-05-22
REGINA
Jules Bordet Institute
Phase 2 Active not recruiting
NCT04787341 2026-05-20
PARERE
Gruppo Oncologico del Nord-Ovest
Phase 2 Active not recruiting
NCT06246643 2026-05-19
A Study of Continued Treatment With Regorafenib in Participants With Solid Tumors Who Have Participated in Other Bayer Studies
Bayer
Phase 2 Active not recruiting